AGC Biologics products

AGC Biologics has an impressive track record of success developing downstream processes for a variety of biotherapeutics including: monoclonal antibodies, recombinant proteins, complex glycoproteins, bacteria and yeast. With insight gained from producing more than 200 biologics to date, we have established downstream platforms that allow us to move quickly into a product’s manufacturing phase. Our experience also enables us to develop more customized and innovative solutions to meet our customers’ needs.